Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Starting SGLT2 inhibitors in the Hospital for Acute HF Gains Support

News Conference News ESC 2025

Starting SGLT2 Inhibitors in the Hospital for Acute HF Gains Support

August 30, 2025

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

News Conference News ESC 2024

Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA

September 04, 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

September 01, 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

Early SGLT2 Inhibition, Spot Urine Sodium Checks May Help in Acute HF

News Conference News ESC 2023

Early SGLT2 Inhibition, Spot Urine Sodium Checks May Help in Acute HF

September 01, 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

News Conference News ESC 2022

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

August 27, 2022

AV Junction Ablation Plus CRT Cuts Deaths in Permanent AF Subset

News Conference News ESC 2021

AV Junction Ablation Plus CRT Cuts Deaths in Permanent AF Subset

September 01, 2021

Implantation Technique Influences LV Remodeling After TMVR

News Conference News ESC 2020

Implantation Technique Influences LV Remodeling After TMVR

September 04, 2020

Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2

News Conference News ESC 2019

Transfer for Primary PCI Still Better Than Fibrinolysis After 16 Years: DANAMI-2

September 04, 2019

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

September 14, 2018

COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure

News Conference News ESC 2018

COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure

August 27, 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

August 27, 2018

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

News Conference News ESC 2018

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

August 25, 2018

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

News Conference News ESC 2017

Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI

Michael O'Riordan

August 28, 2017

News Conference News ESC 2015

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

September 02, 2015

News Conference News ESC 2014

Another Strike Against Thrombectomy in 1-Year TASTE Results

September 02, 2014

News Conference News ESC 2013

BIC-8: Positive Signs for Early-Rule Out of Suspected ACS Using Copeptin

September 03, 2013

News Conference News ESC 2012

Good Outlook for Heart Failure Patients Given Ventricular Restoration Device

Yael L. Maxwell

August 29, 2012

News Conference News

Study Investigates Which Elderly Patients Benefit from Aggressive Treatment

September 01, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.